Proteome Sciences (LON:PRM) Stock Price Down 9.8% – Time to Sell?

Proteome Sciences plc (LON:PRM)’s stock price dropped 9.8% on Wednesday . The company traded as low as GBX 3.18 ($0.04) and last traded at GBX 3.18 ($0.04). Approximately 41,420 shares traded hands during trading, a decline of 55% from the average daily volume of 91,685 shares. The stock had previously closed at GBX 3.52 ($0.04).

Proteome Sciences Price Performance

The business’s 50-day moving average is GBX 2.92 and its two-hundred day moving average is GBX 3.11. The firm has a market cap of £14.17 million, a P/E ratio of -480.00 and a beta of 0.07.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.